Press Releases
China’s domestic pharma industry driving huge machinery influx at P-MEC China
P-MEC China will be held at the Shanghai New International Expo Center (SNIEC), Shanghai, China, from 20-22 June. The event is seen as an accurate gauge of industry growth potential, and features a large exhibition and several in-depth conferences....
Press Releases
The University Hospital Center Zagreb, Croatia, joins Clinerion’s global network of hospitals
The University Hospital Center (UHC) Zagreb brings 1.3 million patients to Clinerion’s network of hospitals, expanding its global footprint into Croatia. UHC Zagreb (in Croatian: Klinički bolnički centar (KBC) Zagreb) has 1,800 beds. The hospital conducted...
Press Releases
Aptar Pharma and Propeller Health Partner to Develop Digital Medicine Platform Across Therapeutic Areas
Aptar Pharma, a leading provider of innovative drug delivery systems, and Propeller Health, a leading digital therapeutics company, announced plans to collaborate on the launch of a comprehensive platform to develop digital medicines for multiple therapeutic areas and diseases....
Press Releases
More Global Recognition for CRF Health’s eSource Solutionswith European Award Win
CRF Health, a leading global provider of patient-centered eSource technology and service solutions for the life sciences industry, announced that the company has been recognized as2018 New Entrant of the Year in Romania’s PIN Awards. Launched...
Press Releases
CPhI report predicts new finished product manufacturing hub in the Middle East
A new report by CPhI forecasts sizable changes ahead for the pharma markets in the Middle East and Africa over the next few years. It highlights recent regulatory changes, coupled with increased geopolitical stability and rising...
Press Releases
Pfizer’s Biosimilar RETACRIT® (epoetin alfa-epbx) Approved by U.S. FDA
Pfizer Inc. announced the United States FDA approved RETACRIT® (epoetin alfa-epbx), a biosimilar to Epogen® and Procrit® (epoetin alfa)1, for all indications of the reference product. RETACRIT is now the first and only biosimilar erythropoiesis-stimulating agent (ESA) to be...
Press Releases
Recipharm invests in Brexit preparations
Recipharm, the contract development and manufacturing organisation (CDMO), has established a dedicated taskforce to manage the potential impact of Brexit on its organisation. With less than a year until the UK exits the European Union (EU),...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read















